Citadel Advisors »

Protagenic Therapeutics Ord shares owned by Citadel Advisors

Quarter-by-quarter ownership of Protagenic Therapeutics Ord (PTIX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Protagenic Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Protagenic Therapeutics Ord held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagenic Therapeutics Ord by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $26k 41k 0.64

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Protagenic Therapeutics Ord

Citadel Advisors
Vanguard Group
Geode Capital Management
Advisor Group Holdings
State Street Corporation
Virtu Financial
Tower Research Capital
Bank of America Corporation
Morgan Stanley
CWM

View all funds holding Protagenic Therapeutics Ord